4
Changes in Ownership
Lexeo Therapeutics, Inc. Filed Acc 0001995218-25-000003
Chief Executive Officer acquired 2,193 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Townsend Richard Nolan · Chief Executive Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-09-12 | Grant or award : show line 1 in the form | +2,193 | $2.64 | $5,798 | 222,251 | D |
Loading xslF345X05/form4-09162025_050903.xml…